What Returns Can You Expect in Ukrainian Defense-Tech?

Start with the number that frames everything. Ukraine went from about $1 billion of annual defense production in 2022 to roughly $35 billion of capacity in 2025, with a projected ~$55 billion in 2026 — and only about a third of 2025 capacity was covered by domestic contracts, leaving a funding gap the country puts near $23 billion for 2026. Against that, disclosed private venture in 2025 was roughly $57 million (PitchBook). The return is not a bet on a new market being created; the market exists and buys at scale. It is a bet on the price of access closing the distance to the output.

Underneath the gap sits a cost basis that does the compounding for you: Ukraine builds an estimated 30–50% below Western Europe, and qualified engineers cost roughly 3–5× less (KSE Institute). A dollar of capital buys more validated capability here than almost anywhere in the alliance.

The return math is forgiving because you are not paying up. Disclosed Ukrainian rounds in 2025 ran from $200–400k early tickets to $2.5–5M at the top, and Brave1's own data puts the average deal between roughly $300k and $1M. You are buying a company with a product already in the field, at a price set before the private market has fully arrived — which is the definition of an entry point, not a momentum trade.

A low entry price is the start; the return comes from three specific ways the value grows, each of which you can diligence before you commit.

• Codification turns one buyer into durable demand. Once a company holds NATO codificationand a US-eligible structure, it can pursue allied programs of record — demand that outlasts any single wartime contract and re-rates the company from “wartime supplier” to “allied vendor.”
• Export-readiness lifts the ceiling. Revenue capped at one domestic customer caps the multiple; an export path opens allied markets, and that is where the multiple expands. Export eligibility is the single biggest value-creation step available before an exit.
• Consolidation creates the strategic bid. A fragmented base of ~1,000 manufacturers rolling up produces buyers — the first realized exit (TAF taking a majority of the Teslia platform) is the proof the strategic bid is now real. The route is mapped in how to exit.

Two 2026 marks anchor the upside case, and both must be read with discipline. Swarmer listed on Nasdaq and traded up several-fold on debut — a real public re-rating, on a thin float. UFORCE raised $50 million at a ~$1 billion valuation while profitable — a genuine benchmark for what a leader is worth. Neither is a return you can bank yet: the first is an illiquid pop, the second a primary markup. But together they set the ceiling the rest of the cohort is priced against, and the distance between a $300k–$1M entry and those marks is the return you are underwriting.

A credible model runs both states. War-continues: demand stays high and domestic, the funding gap keeps pulling in allied money, and the value-creation levers work on schedule. Ceasefire: most of what makes the company valuable survives — a combat-proven product, a trained team, an export path — and rearmament demand across Europe outlasts the war, so the company shifts from wartime supply toward allied procurement. The bear case is a disorderly end that creates a demand air-pocket, which is why the return is underwritten on companies whose value is the technology and the team, not a single contract. Size the position so the MOIC clears your hurdle in the base case and survives the air-pocket in the downside.

This is an early market, so the return is a portfolio outcome, not a single-name bet. Diversify along three axes: product category (drones, EW, counter-UAS, C2, maritime — each with a different demand and threat curve), stage (from pre-revenue-but-validated to revenue and traction), and single-site risk (favor companies with distributed or duplicable production so one strike cannot remove the order book). A concentrated position in one category at one site is the version of this thesis most likely to disappoint.

The return fails in predictable, diligenceable ways, and each has a check you run before you wire:

• A single buyer. A company whose revenue is one domestic contract has no multiple expansion and no floor if that contract resets. Look for a mapped export path.
• Grey IP. Technology sitting on a founder or entangled with grant obligations is a valuation and diligence killer — it may not transfer cleanly on an exit. Confirm the IP is assigned to the company.
• No path to allied markets. Combat-proven is not automatically exportable; without codification and export-readiness the ceiling stays at the domestic budget.